Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial

Polypharmacy in the Aging Patient

(2015) Athanase Benetos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Acute Stroke Intervention

(2015) Shyam Prabhakaran et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-Term Use of Cardiovascular Drugs

(2015) Xavier Rossello et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score

(2015) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity

(2015) A. Marengoni et al.   BMJ-British Medical Journal

Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines

(2015) S. Dumbreck et al.   BMJ-British Medical Journal

Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity

(2015) A. Marengoni et al.   BMJ-British Medical Journal

Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines

(2015) S. Dumbreck et al.   BMJ-British Medical Journal

Effect of Discontinuation of Antihypertensive Treatment in Elderly People on Cognitive Functioning—the DANTE Study Leiden

(2015) Justine E. F. Moonen et al.   JAMA Internal Medicine

Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness

(2015) Jean S. Kutner et al.   JAMA Internal Medicine

Reducing Inappropriate Polypharmacy

(2015) Ian A. Scott et al.   JAMA Internal Medicine

Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study

(2014) Valeria Raparelli et al.   Internal and Emergency Medicine

Multimorbidity and polypharmacy in the elderly: lessons from REPOSI

(2014) Pier Mannuccio Mannucci et al.   Internal and Emergency Medicine

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

(2014) Raffaele de Caterina et al.   THROMBOSIS AND HAEMOSTASIS

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

(2013) Gregory Y.H. Lip et al.   EUROPACE

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

(2013) Pilar Gallego et al.   THROMBOSIS AND HAEMOSTASIS

Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

(2013) Raffaele Caterina et al.   THROMBOSIS AND HAEMOSTASIS

Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study

(2011) Alessandro Nobili et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Association between clusters of diseases and polypharmacy in hospitalized elderly patients: Results from the REPOSI study

(2011) Alessandro Nobili et al.   European Journal of Internal Medicine

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Polypharmacy Status as an Indicator of Mortality in an Elderly Population

(2009) Johanna Jyrkkä et al.   DRUGS & AGING